Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months

Fig. 2

Work productivity and activity impairment in UC patients (mITTe set). The mean change in total work productivity impairment (TWPI, a) and activity impairment (b) is shown for month 3 and for month 24 (both primary endpoints). For both impairments a statistically significant improvement was observed at month 3 and month 24, respectively. For absenteeism (c) as well as presenteeism (d), similar outcomes were reported. ad Analyses were performed for the mITT analysis set employed at BL (mITTe set). Data were shown as mean change (SD) from baseline in %. n: number of patients. BL: baseline. SD: standard deviation

Back to article page